Neoadjuvant chemotherapy for resectable colorectal cancer liver metastases: Impact on magnitude of liver resection and survival.

@article{Gruenberger2004NeoadjuvantCF,
  title={Neoadjuvant chemotherapy for resectable colorectal cancer liver metastases: Impact on magnitude of liver resection and survival.},
  author={Thomas Gruenberger and Birgit Schuell and Gabriela Verena Kornek and Werner Scheithauer},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2004},
  volume={22 14_suppl},
  pages={3598}
}
3598 Background: Curative liver resection remains the best treatment option for colorectal liver metastases (CRCLM). Overall survival is still limited due to high recurrence rates. Adjuvant chemotherapy was ineffective in reducing recurrence, therefore neoadjuvant treatment was explored. METHODS During the last two years 50 patients were treated with 6 cycles of neoadjuvant chemotherapy prior to liver resection for CRCLM. Chemotherapy consisted of Oxaliplatin/5-FU/LV according to FOLFOX4… CONTINUE READING
9 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…